M. C. Pardo

Comparison of the safety and efficacy of a recombinant feline leukemia virus (FeLV) vaccine delivered transdermally and an inactivated FeLV vaccine delivered subcutaneously.

L. Motes-Kreimeyer, D. Grosenbaugh, T. Leard, 2004, Veterinary therapeutics : research in applied veterinary medicine.

Evaluation of myometrial invasion in endometrial cancer: comparison of diffusion-weighted magnetic resonance and intraoperative frozen sections

J. C. Gallego, A. Porta, M. C. Pardo, 2014, Abdominal Imaging.

Safety of a new modified live virus vaccine against canine coronavirus.

M. Maćkowiak, M. C. Pardo, 2000 .

Efficacy of a new canine origin, modified live virus vaccine against canine coronavirus

M. C. Pardo, M. Mackowlak, 1999 .

Development and registration of recombinant veterinary vaccines. The example of the canarypox vector platform.

H. Poulet, V. Juillard, M. C. Pardo, 2007, Vaccine.

Protection from challenge following administration of a canarypox virus-vectored recombinant feline leukemia virus vaccine in cats previously vaccinated with a killed virus vaccine.

D. Grosenbaugh, T. Leard, M. C. Pardo, 2006, Journal of the American Veterinary Medical Association.

Protection of dogs against canine distemper by vaccination with a canarypox virus recombinant expressing canine distemper virus fusion and hemagglutinin glycoproteins.

M. Maćkowiak, M. C. Pardo, J. Bauman, 1997, American journal of veterinary research.

DISPOSITION OF ADOLESCENTS TOWARD RECEIVING COVID-19 VACCINATIONS IN VILLAVICENCIO: MYTHS AND BELIEFS

M. C. Pardo, M. Echavarría, C. García Balaguera, 2023, medRxiv.

Immunization of Puppies in the Presence of Maternally Derived Antibodies Against Canine Distemper Virus

L. Fischer, M. C. Pardo, J. Bauman, 2007, Journal of Comparative Pathology.

Occurrence of Canine Parvovirus Type 2c in the United States

J. Saliki, S. Sanchez, C. Buonavoglia, 2007, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

Fifteen-month duration of immunity for the serovar Grippotyphosa fraction of a tetravalent canine leptospirosis vaccine

D. Grosenbaugh, M. C. Pardo, 2018, Veterinary Record.

Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.

P. Guigal, D. Jessett, M. Bublot, 2007, American journal of veterinary research.

Early cryoprecipitate transfusion versus standard care in severe postpartum haemorrhage: a pilot cluster‐randomised trial

L. Green, D. Lanz, T. Pérez, 2021, Anaesthesia.